Gary S. Jacob
Known title: Chief Executive OfficerCIK: 0001266802
Gary S. Jacob's purchase track record
Gary S. Jacob has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/19/2022 | OKYO | $50K | -30.3% | -33.9% | +1.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| OKYO | ▲ Buy | Grant | 3,500 | $5K | 7/21/2026 | View on chart |
| OKYO | ▲ Buy | Open Market | 12,500 | $50K | 5/19/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
OKYO Pharma to Present at Ophthalmic Scientific Conferences
OKYO Pharma announced it will present and participate in several upcoming ophthalmic scientific conferences. The company’s involvement highlights its focus on eye‑care products and may increase visibility among researchers and clinicians. This activity could support interest in OKYO’s pipeline as the firm seeks to advance its ophthalmic therapies.
OKYO Pharma to Present at Ophthalmic Scientific Conferences. OKYO Pharma announced it will present and participate in several upcoming ophthalmic scientific conferences. The company’s involvement highlights its focus on eye‑care products and may increase visibility among researchers and clinicians. This activity could support interest in OKYO’s pipeline as the firm seeks to advance its ophthalmic therapies.